Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May-Jun;68(3):391-8.
doi: 10.1016/j.ihj.2015.07.004. Epub 2015 Aug 29.

Risk assessment in the prevention of cardiovascular disease in low-resource settings

Sandra N Ofori  1 , Osaretin J Odia  2
Affiliations
Review

Risk assessment in the prevention of cardiovascular disease in low-resource settings

Sandra N Ofori et al. Indian Heart J. 2016 May-Jun.

Abstract

Introduction: Cardiovascular disease (CVD) prevalence is increasing in low- and middle-income countries. Total risk assessment is key to prevention.

Methods: Studies and guidelines published between 1990 and 2013 were sought using Medline database, PubMed, and World Health Organization report sheets. Search terms included 'risk assessment' and 'cardiovascular disease prevention'. Observational studies and randomized controlled trials were reviewed.

Results: The ideal risk prediction tool is one that is derived from the population in which it is to be applied. Without national population-based cohort studies in sub-Saharan African countries like Nigeria, there is no tool that is used consistently. Regardless of which one is adopted by national guidelines, routine consistent use is advocated by various CVD prevention guidelines.

Conclusions: In low-resource settings, the consistent use of simple tools like the WHO charts is recommended, as the benefit of a standard approach to screening outweighs the risk of missing an opportunity to prevent CVD.

Keywords: Cardiovascular disease prevention; Cardiovascular diseases; Risk assessment; Risk markers.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Perk J., De Backer G., Gohlke H. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur Heart J. 2012;33:1635–1701. - PubMed
    1. Naghavi M., Wang H., Lozano R. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 - PMC - PubMed
    1. Fuster V., Kelly B.B., Vedanthan R. Promoting global cardiovascular health: moving forward. Circulation. 2011;123:1671–1678. - PubMed
    1. Allender S., Scarborough P., Peto V. vol. 3. European Heart Network; Brussels, London: 2008. pp. 11–35. (European Cardiovascular Disease Statistics).
    1. Yusuf S., Islam S., Chow C.K. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378:1231–1243. - PubMed

LinkOut - more resources